Solco Healthcare is recalling all lots of Valsartan tablets and Valsartan-Hydrochlorothiazide tablets, which are used for treatment of hypertension, or high blood pressure.
A trace amount of an unexpected impurity -- N-nitrosodimethylamine (NDMA) -- was detected. NDMA has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.
The company has received no reports of adverse events related to this recall.
The following products are being recalled:
What to do
Solco is notifying customers by letter and email and is arranging for return of all recalled products.
Consumers with questions may contact the company at (866) 931-9829, option 5, Monday through Friday, 9:00 a.m. – 5:00 p.m. (EST), or by email at email@example.com.
Keep an eye on your inbox, the lastest consumer news is on it's way!